• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚硫酸戊聚糖钙是一种多方面的聚集蛋白聚糖酶外位点抑制剂。

Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.

作者信息

Troeberg Linda, Fushimi Kazunari, Khokha Rama, Emonard Hervé, Ghosh Peter, Nagase Hideaki

机构信息

Kennedy Institute of Rheumatology Division, Imperial College London, 65 Aspenlea Rd, Hammersmith, London, W6 8LH, UK.

出版信息

FASEB J. 2008 Oct;22(10):3515-24. doi: 10.1096/fj.08-112680. Epub 2008 Jul 16.

DOI:10.1096/fj.08-112680
PMID:18632849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2537431/
Abstract

Degradation of the cartilage proteoglycan aggrecan is a key early event in the development of osteoarthritis. Adamalysin with thrombospondin motifs (ADAMTS) -4 and ADAMTS-5 are considered to be the main enzymes responsible for aggrecan breakdown, making them attractive drugs targets. Here we show that calcium pentosan polysulfate (CaPPS), a chemically sulfated xylanopyranose from beechwood, is a multifaceted exosite inhibitor of the aggrecanases and protects cartilage against aggrecan degradation. CaPPS interacts with the noncatalytic spacer domain of ADAMTS-4 and the cysteine-rich domain of ADAMTS-5, blocking activity against their natural substrate aggrecan with inhibitory concentration 50 values of 10-40 nM but only weakly inhibiting hydrolysis of a nonglycosylated recombinant protein substrate. In addition, CaPPS increased cartilage levels of tissue inhibitor of metalloproteinases-3 (TIMP-3), an endogenous inhibitor of ADAMTS-4 and -5. This was due to the ability of CaPPS to block endocytosis of TIMP-3 mediated by low-density lipoprotein receptor-related protein. CaPPS also increased the affinity of TIMP-3 for ADAMTS-4 and -5 by more than 100-fold, improving the efficacy of TIMP-3 as an aggrecanase inhibitor. Studies with TIMP-3-null mouse cartilage indicated that CaPPS inhibition of aggrecan degradation is TIMP-3 dependent. These unique properties make CaPPS a prototypic disease-modifying agent for osteoarthritis.

摘要

软骨蛋白聚糖聚集蛋白聚糖的降解是骨关节炎发展过程中的一个关键早期事件。含血小板反应蛋白基序的解聚素(ADAMTS)-4和ADAMTS-5被认为是负责聚集蛋白聚糖分解的主要酶,这使其成为有吸引力的药物靶点。在此我们表明,戊聚糖硫酸钙(CaPPS),一种来自山毛榉木的化学硫酸化吡喃木糖,是聚集蛋白聚糖酶的多方面外位点抑制剂,并能保护软骨免受聚集蛋白聚糖降解。CaPPS与ADAMTS-4的非催化间隔域和ADAMTS-5的富含半胱氨酸域相互作用,以10 - 40 nM的半数抑制浓度阻断对其天然底物聚集蛋白聚糖的活性,但仅微弱抑制非糖基化重组蛋白底物的水解。此外,CaPPS提高了金属蛋白酶组织抑制剂-3(TIMP-3)的软骨水平,TIMP-3是ADAMTS-4和-5的内源性抑制剂。这是由于CaPPS能够阻断由低密度脂蛋白受体相关蛋白介导的TIMP-3的内吞作用。CaPPS还使TIMP-3对ADAMTS-4和-5的亲和力提高了100多倍,提高了TIMP-3作为聚集蛋白聚糖酶抑制剂的功效。对TIMP-3基因敲除小鼠软骨的研究表明,CaPPS对聚集蛋白聚糖降解的抑制作用是TIMP-3依赖性的。这些独特特性使CaPPS成为骨关节炎的一种原型疾病改善剂。

相似文献

1
Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases.聚硫酸戊聚糖钙是一种多方面的聚集蛋白聚糖酶外位点抑制剂。
FASEB J. 2008 Oct;22(10):3515-24. doi: 10.1096/fj.08-112680. Epub 2008 Jul 16.
2
Aggrecanase and aggrecan degradation in osteoarthritis: a review.骨关节炎中的聚集蛋白聚糖酶与聚集蛋白聚糖降解:综述
J Int Med Res. 2008 Nov-Dec;36(6):1149-60. doi: 10.1177/147323000803600601.
3
Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase-1) in osteoarthritic chondrocytes.戊聚糖多硫酸钙直接抑制骨关节炎软骨细胞中ADAMTS4(聚糖酶-1)的酶活性。
FEBS Lett. 2008 Aug 20;582(19):2945-9. doi: 10.1016/j.febslet.2008.07.036. Epub 2008 Jul 29.
4
Drug insight: aggrecanases as therapeutic targets for osteoarthritis.药物洞察:聚蛋白聚糖酶作为骨关节炎的治疗靶点
Nat Clin Pract Rheumatol. 2008 Aug;4(8):420-7. doi: 10.1038/ncprheum0841. Epub 2008 Jun 24.
5
Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.N-TIMP-3 的反应位点突变体,选择性抑制 ADAMTS-4 和 ADAMTS-5:生物学和结构意义。
Biochem J. 2010 Oct 1;431(1):113-22. doi: 10.1042/BJ20100725.
6
ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.ADAMTS-4 和 ADAMTS-5:骨关节炎中的关键酶。
J Cell Biochem. 2011 Dec;112(12):3507-14. doi: 10.1002/jcb.23298.
7
TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4.基质金属蛋白酶组织抑制因子-3(TIMP-3)对含血小板反应蛋白基序的解聚蛋白样金属蛋白酶-4(ADAMTS-4,也称软骨聚集蛋白聚糖酶-1)的抑制作用受软骨聚集蛋白聚糖与ADAMTS-4 C端结构域之间相互作用的调节。
J Biol Chem. 2007 Jul 20;282(29):20991-8. doi: 10.1074/jbc.M610721200. Epub 2007 Apr 30.
8
Calcium pentosan polysulfate inhibits the catabolism of aggrecan in articular cartilage explant cultures.戊聚糖多硫酸钙抑制关节软骨外植体培养中聚集蛋白聚糖的分解代谢。
Arthritis Rheum. 2000 Oct;43(10):2211-8. doi: 10.1002/1529-0131(200010)43:10<2211::AID-ANR8>3.0.CO;2-D.
9
Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 binding.低密度脂蛋白受体相关蛋白 1(LRP1)介导热激金属蛋白酶与血小板反应蛋白 4(ADAMTS-4)的内吞清除:ADAMTS-4 和 ADAMTS-5 的非催化结构域在 LRP1 结合中的功能差异。
J Biol Chem. 2014 Mar 7;289(10):6462-6474. doi: 10.1074/jbc.M113.545376. Epub 2014 Jan 28.
10
Aggrecanases and cartilage matrix degradation.聚集蛋白聚糖酶与软骨基质降解
Arthritis Res Ther. 2003;5(2):94-103. doi: 10.1186/ar630. Epub 2003 Feb 14.

引用本文的文献

1
Skeletal progenitor LRP1 deficiency causes severe and persistent skeletal defects with Wnt pathway dysregulation.骨骼祖细胞LRP1缺乏会导致严重且持续的骨骼缺陷,并伴有Wnt信号通路失调。
Bone Res. 2025 Jan 26;13(1):17. doi: 10.1038/s41413-024-00393-x.
2
Pentosan polysulfate sodium promotes redifferentiation to the original phenotype in micromass-cultured canine articular chondrocytes and exerts molecular weight-dependent effects.戊聚糖多硫酸钠促进微团培养的犬关节软骨细胞向原始表型的再分化,并发挥分子量依赖性作用。
J Vet Med Sci. 2023 Jun 14;85(6):680-690. doi: 10.1292/jvms.22-0567. Epub 2023 May 8.
3
Pentosan Polysulfate Affords Pleotropic Protection to Multiple Cells and Tissues.聚硫酸戊聚糖对多种细胞和组织具有多向性保护作用。
Pharmaceuticals (Basel). 2023 Mar 13;16(3):437. doi: 10.3390/ph16030437.
4
The effect of pentosan polysulfate sodium for improving dyslipidaemia and knee pain in people with knee osteoarthritis: A pilot study.戊聚糖多硫酸酯钠对改善膝骨关节炎患者血脂异常和膝关节疼痛的作用:一项初步研究。
Osteoarthr Cartil Open. 2023 Feb 7;5(2):100343. doi: 10.1016/j.ocarto.2023.100343. eCollection 2023 Jun.
5
Targeting Aggrecanases for Osteoarthritis Therapy: From Zinc Chelation to Exosite Inhibition.靶向聚集素酶治疗骨关节炎:从锌螯合到外位点抑制。
J Med Chem. 2022 Oct 27;65(20):13505-13532. doi: 10.1021/acs.jmedchem.2c01177. Epub 2022 Oct 17.
6
ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.ADAM 和 ADAMTS 解整合素金属蛋白酶作为血管功能障碍和疾病的主要因素和分子靶点。
Adv Pharmacol. 2022;94:255-363. doi: 10.1016/bs.apha.2021.11.002. Epub 2022 Jan 24.
7
Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding.金属蛋白酶组织抑制剂3(TIMP-3):体内分析证实其作为胞外域脱落主要调节因子的作用。
Membranes (Basel). 2022 Feb 11;12(2):211. doi: 10.3390/membranes12020211.
8
CircSLC7A2 protects against osteoarthritis through inhibition of the miR-4498/TIMP3 axis.环状 RNA SLC7A2 通过抑制 miR-4498/TIMP3 轴对骨关节炎起保护作用。
Cell Prolif. 2021 Jun;54(6):e13047. doi: 10.1111/cpr.13047. Epub 2021 May 7.
9
Targeting Cartilage Degradation in Osteoarthritis.针对骨关节炎中的软骨降解
Pharmaceuticals (Basel). 2021 Feb 5;14(2):126. doi: 10.3390/ph14020126.
10
Integrative Analysis of MicroRNA and mRNA Sequencing Data Identifies Novel Candidate Genes and Pathways for Developmental Dysplasia of Hip.整合 miRNA 和 mRNA 测序数据分析鉴定发育性髋关节发育不良的新候选基因和途径。
Cartilage. 2021 Dec;13(2_suppl):1618S-1626S. doi: 10.1177/1947603521990859. Epub 2021 Feb 1.

本文引用的文献

1
Effects of pentosan polysulfate in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled pilot study.戊聚糖多硫酸盐对膝骨关节炎的影响:一项随机、双盲、安慰剂对照的试点研究。
Curr Ther Res Clin Exp. 2005 Nov;66(6):552-71. doi: 10.1016/j.curtheres.2005.12.012.
2
Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?重新审视类风湿性关节炎和骨关节炎中的金属蛋白酶:破坏还是修复?
Nat Clin Pract Rheumatol. 2008 Mar;4(3):128-35. doi: 10.1038/ncprheum0727.
3
Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity.人ADAMTS-4和ADAMTS-5催化结构域与非催化结构域在蛋白聚糖分解活性方面的功能差异。
J Biol Chem. 2008 Mar 14;283(11):6706-16. doi: 10.1074/jbc.M708647200. Epub 2007 Dec 22.
4
Screening of potential a disintegrin and metalloproteinase with thrombospondin motifs-4 inhibitors using a collagen model fluorescence resonance energy transfer substrate.使用胶原模型荧光共振能量转移底物筛选具有血小板反应蛋白基序-4的潜在解聚素和金属蛋白酶抑制剂。
Anal Biochem. 2008 Feb 1;373(1):43-51. doi: 10.1016/j.ab.2007.09.014. Epub 2007 Sep 15.
5
5'-Phenyl-3'H-spiro[indoline-3,2'-[1,3,4]thiadiazol]-2-one inhibitors of ADAMTS-5 (aggrecanase-2).5'-苯基-3'H-螺[吲哚啉-3,2'-[1,3,4]噻二唑]-2-酮,ADAMTS-5(软骨聚集蛋白聚糖酶-2)的抑制剂
Bioorg Med Chem Lett. 2007 Oct 15;17(20):5630-3. doi: 10.1016/j.bmcl.2007.07.048. Epub 2007 Aug 19.
6
TIMP-3 inhibition of ADAMTS-4 (Aggrecanase-1) is modulated by interactions between aggrecan and the C-terminal domain of ADAMTS-4.基质金属蛋白酶组织抑制因子-3(TIMP-3)对含血小板反应蛋白基序的解聚蛋白样金属蛋白酶-4(ADAMTS-4,也称软骨聚集蛋白聚糖酶-1)的抑制作用受软骨聚集蛋白聚糖与ADAMTS-4 C端结构域之间相互作用的调节。
J Biol Chem. 2007 Jul 20;282(29):20991-8. doi: 10.1074/jbc.M610721200. Epub 2007 Apr 30.
7
Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4.人ADAMTS-5的蛋白水解活性:与ADAMTS-4的比较研究
J Biol Chem. 2007 Jun 22;282(25):18294-18306. doi: 10.1074/jbc.M701523200. Epub 2007 Apr 12.
8
Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice.随着年龄增长,Timp3基因敲除小鼠关节中胶原蛋白和聚集蛋白聚糖的降解增加。
Arthritis Rheum. 2007 Mar;56(3):905-9. doi: 10.1002/art.22427.
9
Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.人关节软骨外植体中的聚集蛋白聚糖降解由ADAMTS - 4和ADAMTS - 5共同介导。
Arthritis Rheum. 2007 Feb;56(2):575-85. doi: 10.1002/art.22334.
10
Synthesis and evaluation of aryl thioxothiazolidinone inhibitors of ADAMTS-5 (Aggrecanase-2).ADAMTS-5(软骨聚集蛋白聚糖酶-2)的芳基硫代噻唑烷酮抑制剂的合成与评价
Bioorg Med Chem Lett. 2007 Mar 1;17(5):1185-8. doi: 10.1016/j.bmcl.2006.12.027. Epub 2006 Dec 12.